Anzeige
Mehr »
Sonntag, 13.09.2026 - Börsentäglich über 12.000 News
Flucht aus dem Dollar? Gold explodiert - und hier wurden historische 80,4 g/t erbohrt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Frankfurt
11.09.26 | 08:02
3,440 Euro
0,00 % 0,000
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,5203,58012.09.
3,4603,64011.09.

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.09.Lifecore Strikes Tech Transfer Deal for Commercial Manufacturing of Major Pharma Company Injectable1
02.09.Lifecore Biomedical rises on deal with global pharma company1
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
02.09.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company193-- Significant New Program Positioned to Become One of Lifecore's Largest Contracts -- -- Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Drug Product -- --...
► Artikel lesen
17.08.Core Thesis on Lifecore Biomedical (LFCR): Monetizing Excess Production2
05.08.Lifecore reaffirms 2026 guidance, outlines fill/finish demand doubling in 2027 and +200% growth in 20283
05.08.LIFECORE BIOMEDICAL, INC. \DE\ - 10-Q, Quarterly Report1
05.08.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
05.08.Lifecore Biomedical, Inc.: Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update373-- Reaffirms 2026 Guidance -- -- Multiple New Business Wins, Adding Impactful Programs to Pipeline -- -- Cost Reduction and Productivity Enhancements Continue to Strengthen Organization -- Conference...
► Artikel lesen
29.07.Lifecore Biomedical, Inc.: Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 20262
28.07.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs Three New Customer Agreements244--Technology Transfer Agreement for Regenerative Medicine Late-Stage Development Program-- --Two Additional Agreements Supporting Early-Stage Programs Including Formulation and Development for a Global...
► Artikel lesen
15.07.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)1
15.07.Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market2
02.07.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
15.06.Lifecore Biomedical signs manufacturing deal for neurology product1
15.06.Lifecore Biomedical schließt Produktionsvertrag für Neurologie-Präparat1
15.06.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company578--Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Neurology Product-- --Seventh Addition to Lifecore's Late-Stage Pipeline in Seven Months-- CHASKA, Minn., June...
► Artikel lesen
05.06.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
03.06.Lifecore Biomedical Signs Tech Transfer Agreement for Ophthalmic6
02.06.Lifecore Biomedical, Inc.: Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer1
06.05.Lifecore Biomedical Q1 2026 Earnings Call Transcript1
Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1